Crossmark

The relationship between trust in federal oversight of vaccine safety and willingness to participate in COVID-19 clinical trials: a repeated measures study of Philadelphia residents (September 2021 – March 2023)

Crossref DOI link: https://doi.org/10.1186/s12889-024-19602-7

Published Online: 2024-07-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Hyunmin

Bauermeister, José

Oyiborhoro, Ufuoma

Morales, Knashawn

Aryal, Subhash

Glanz, Karen

Villarruel, Antonia

Bonett, Stephen
Funding

Funding for this research was provided by:

National Institutes of Health (1OT2HL161568)
License Information

Text and Data Mining valid from 2024-07-31

Version of Record valid from 2024-07-31
More Information

Article History

Received: 19 April 2024

Accepted: 25 July 2024

First Online: 31 July 2024

Declarations

:

: All study procedures received approval from the University of Pennsylvania Institutional Review Board (IRB protocol number: 848650). Written informed consent was obtained from all participants after fully explaining the nature and potential consequences of the study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below